Structured evidence table for Soy Protein Cholesterol Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Soy Protein Cholesterol Meta-Analysis | Effects of soy and isoflavone interventions on plasma lipid profiles in postmenopausal women: an umbrella review | 3 | Guo J (2026) | Effects of soy and isoflavone interventions on plasma lipid profiles in postmenopausal women: an umbrella review |
| Soy Protein Cholesterol Meta-Analysis | Dyslipidemias, particularly those associated with an increase in the circulating burden of atherogenic apolipoprotein (Apo) B-containing lipoproteins, such as hypercholesterolemia (elevated total cholesterol and low-density lipoprotein cholesterol [LDL-C]), hypertriglyceridemia (elevated triglycerides [TG]), and mixed dyslipidemia (elevated LDL-C and TG), are well-established ASCVD risk factors [,,]. | 3 | Maki Kevin C. (2026) | Effects of Dietary Protein Quantity, Source, and Type on Plasma Lipids and Lipoproteins and Their Roles in Dyslipidemia Management in Humans |
| Soy Protein Cholesterol Meta-Analysis | LDL-C and non-high-density lipoprotein cholesterol (non-HDL-C), which is calculated as the concentration of total cholesterol minus the concentration of high-density lipoprotein cholesterol (HDL-C) and is a comprehensive measurement of cholesterol carried by all Apo B-containing lipoproteins, are the targets for therapies to lower ASCVD risk []. | 3 | Maki Kevin C. (2026) | Effects of Dietary Protein Quantity, Source, and Type on Plasma Lipids and Lipoproteins and Their Roles in Dyslipidemia Management in Humans |
| Soy Protein Cholesterol Meta-Analysis | Changes in both have been shown to predict changes in risk, and these relationships are believed to reflect a causal association of the burden of atherogenic lipoprotein particles with the initiation and progression of ASCVD. | 3 | Maki Kevin C. (2026) | Effects of Dietary Protein Quantity, Source, and Type on Plasma Lipids and Lipoproteins and Their Roles in Dyslipidemia Management in Humans |
| Soy Protein Cholesterol Meta-Analysis | 1 1 2 3 4 5 6 Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of death worldwide []. | 3 | Maki Kevin C. (2026) | Effects of Dietary Protein Quantity, Source, and Type on Plasma Lipids and Lipoproteins and Their Roles in Dyslipidemia Management in Humans |
Source documents